Results 101 to 110 of about 34,277 (277)

Retinal Thinning as a Marker of Disease Severity in Progressive Supranuclear Palsy [PDF]

open access: diamond, 2023
Yueting Chen   +15 more
openalex   +1 more source

Noninvasive imaging of amyloid‐beta and tau in rodent and nonhuman primate models

open access: yesVIEW, EarlyView.
Imaging of amyloid‐beta plaque and tau accumulation in rodent and nonhuman primate model of Alzheimer's disease. Created in BioRender. Ni R. 2026. https://BioRender.com/a97h5ec Abstract Neurodegenerative diseases are characterized by the aberrant accumulation of protein aggregates.
Ruiqing Ni, Axel Rominger
wiley   +1 more source

Diagnoses behind patients with hard-to-classify tremor and normal DaT-SPECT: a clinical follow up study [PDF]

open access: yes, 2014
The [(123)I]ioflupane—a dopamine transporter radioligand—SPECT (DaT-SPECT) has proven to be useful in the differential diagnosis of tremor. Here, we investigate the diagnoses behind patients with hard-to-classify tremor and normal DaT-SPECT.
Arias Carrión, Óscar   +4 more
core   +1 more source

Diagnostic Value of Bedside Eye Movement Examination in Movement Disorders

open access: yes
Movement Disorders Clinical Practice, EarlyView.
Eloísa Bittencurt Thomaz de Assis   +4 more
wiley   +1 more source

Sialylation patterns in cerebral amyloid angiopathy

open access: yesBrain Pathology, EarlyView.
This study is the first to localize and evaluate sialylation modifications in the context of Alzheimer's Disease and Cerebral Amyloid Angiopathy, revealing a unique disease‐specific increase in intravascular sialylation. Abstract Glycosylation is the most common form of post‐translational modification in the brain and becomes significantly altered in ...
Caitlyn Fastenau   +8 more
wiley   +1 more source

Diplopia and eye movement disorders.

open access: yes, 2004
Published ...
Danchaivijitr, C, Kennard, C
core   +2 more sources

Behavioral and Neurophysiological Effects of Transdermal Rotigotine in Atypical Parkinsonism [PDF]

open access: yes, 2014
Effective therapies for the so-called atypical parkinsonian syndrome (APS) such as multiple system atrophy (MSA), progressive supranuclear palsy (PSP), or corticobasal syndrome (CBS) are not available.
Davide Vito Moretti   +3 more
core   +2 more sources

Challenges with the differential diagnosis of progressive supranuclear palsy and Parkinson’s disease

open access: yesАнналы клинической и экспериментальной неврологии, 2017
Progressive supranuclear palsy (PSP) is a severe old-age neurodegenerativedisease that is characterized by pronouncedclinical polymorphism and has different phenotypes.
R. V. Magzhanov   +5 more
doaj   +1 more source

3D imaging of neuronal inclusions and protein aggregates in human neurodegeneration by multiscale x‐ray phase‐contrast tomography

open access: yesBrain Pathology, EarlyView.
x‐ray phase‐contrast tomography enabled three‐dimensional, label‐free visualization and quantification of protein aggregates in neurodegenerative diseases with isotropic submicrometer resolution. The study revealed distinct electron density patterns in Lewy bodies, Hirano bodies, granulovacuolar degeneration, and amyloid plaques, highlighting their ...
Jonas Franz   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy